CK1-IN-3

• CAT Number: I040955
• CAS Number: 349438-74-0
• Molecular Formula: C17H16N2O3S
• Molecular Weight: 328.39
• Purity: ≥95%
• Synonyms: N-(6-methoxy-1,3-benzothiazol-2-yl)-2-(2-methoxyphenyl)acetamide
• InChI: InChI=1S/C17H16N2O3S/c1-21-12-7-8-13-15(10-12)23-17(18-13)19-16(20)9-11-5-3-4-6-14(11)22-2/h3-8,10H,9H2,1-2H3,(H,18,19,20)
• InChIKey: HFBLBLSJZDGKCC-UHFFFAOYSA-N
• SMILES: COC1=CC2=C(C=C1)N=C(S2)NC(=O)CC3=CC=CC=C3OC

CK1-IN-3(CAT: I040955) is a potent inhibitor of Casein Kinase 1 (CK1), a serine/threonine kinase involved in multiple cellular processes, including circadian rhythm regulation, Wnt signaling, and DNA damage response. Dysregulation of CK1 activity has been implicated in various diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. By inhibiting CK1, CK1-IN-3 may modulate key signaling pathways associated with Cancer Disease Research, particularly in tumors where aberrant CK1 activity contributes to cell proliferation and survival. This inhibitor is a valuable tool for studying CK1-mediated signaling and exploring potential therapeutic strategies targeting CK1-dependent pathways in oncology and beyond.